Tuesday, April 30, 2024
English English French Spanish Italian Korean Japanese Russian Hindi Chinese (Simplified)

Community pharmacies serve a crucial role in today’s healthcare landscape, extending beyond mere prescription filling to become trusted and accessible healthcare providers. Patients rely on their local pharmacists more than ever, with surveys indicating a staggering 90% trust in pharmacy teams. However, the current reimbursement model for these pharmacies often fails to reflect their true value and operational costs.

To address this disparity, CVS Pharmacy is leading the charge with CVS CostVantage, set to launch in 2025 for commercial payors. This groundbreaking initiative aims to realign pharmacy reimbursement with the quality services provided and prescriptions dispensed. By doing so, CVS CostVantage not only ensures the sustainability of community pharmacies but also enhances transparency for pharmacy benefit managers (PBMs) and payors.

Prem Shah, Executive Vice President, Chief Pharmacy Officer, and President of Consumer Wellness at CVS Health, emphasizes the importance of CVS CostVantage in a recent article published in Fierce Healthcare. This initiative represents a significant step towards a more transparent and equitable reimbursement model, benefiting all stakeholders involved.

With CVS CostVantage, CVS Pharmacy is revolutionizing reimbursement practices, recognizing and rewarding the invaluable contributions of community pharmacies while advancing healthcare accessibility and affordability for all.

Subscribe

* indicates required

The Enterprise is an online business news portal that offers extensive reportage of corporate, economic, financial, market, and technology news from around the world. Visit to explore daily national, international & business news, track market movements, and read succinct coverage of significant events. The Enterprise is also your reach vehicle to connect with, and read about senior business executives.

Address: 150th Ct NE, Redmond, WA 98052-4166

©2024 The Enterprise – All Right Reserved.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept